Metadata

Name CCU002_02 Chronic obstructive pulmonary disease (COPD)
Type Disease or Syndrome
Group Disease or Syndrome
Data Sources




Clinical Terminologies SNOMED-CT
ICD-10
Codelists covid_impact_ccu00202_COPD_England_ICD10.csv covid_impact_ccu00202_COPD_England_SNOMEDCT.csv
Valid Event Data Range 08/12/2020 - 18/03/2021
Sex Female
Male
Authors CVD-COVID-UK consortium, William N Whiteley, Samantha Ip, Jennifer A Cooper, Thomas Bolton, Spencer Keene, Venexia Walker, Rachel Denholm, Ashley Akbari, Efosa Omigie, Sam Hollings, Emanuele Di Angelantonio, Spiros Denaxas, Angela Wood, Jonathan A C Sterne, Cathie Sudlow
Agreement Date 23 Aug 2021
Version (UUID) Revision 1 (COVID-IMPACT)

Phenotypes

Code type is set to 1 for incident events, and 0 for prevalent events.

England hospitalization EHR: COPD diagnosis

terminology code term code_type
ICD10 J40 Bronchitis not specified as acute or chronic 1.0
ICD10 J41 Simple and mucopurulent chronic bronchitis 1.0
ICD10 J42 Unspecified chronic bronchitis 1.0
ICD10 J43 Emphysema 1.0
ICD10 J44 Other chronic obstructive pulmonary disease 1.0

England primary care EHR: COPD diagnosis

terminology code term code_type
SNOMEDCT 196027008 Toxic bronchiolitis obliterans (disorder) 1.0
SNOMEDCT 32544004 Chronic obliterative bronchiolitis caused by inhalation of chemical fumes AND/OR vapors (disorder) 1.0
SNOMEDCT 40100001 Obliterative bronchiolitis (disorder) 1.0
SNOMEDCT 77690003 Interstitial emphysema of lung (disorder) 1.0
SNOMEDCT 135836000 End stage chronic obstructive airways disease (disorder) 1.0
SNOMEDCT 13645005 Chronic obstructive lung disease (disorder) 1.0
SNOMEDCT 185086009 Chronic obstructive bronchitis (disorder) 1.0
SNOMEDCT 195949008 Chronic asthmatic bronchitis (disorder) 1.0
SNOMEDCT 195959009 Zonal bullous emphysema (disorder) 1.0
SNOMEDCT 196026004 Chronic emphysema caused by chemical fumes (disorder) 1.0
SNOMEDCT 233672007 Byssinosis grade 3 (disorder) 1.0
SNOMEDCT 233674008 Pulmonary emphysema in alpha-1 primary immunodeficiency deficiency (disorder) 1.0
SNOMEDCT 266355005 Bullous emphysema with collapse (disorder) 1.0
SNOMEDCT 266356006 Atrophic (senile) emphysema (disorder) 1.0
SNOMEDCT 293991000000106 Very severe chronic obstructive pulmonary disease (disorder) 1.0
SNOMEDCT 313297008 Moderate chronic obstructive pulmonary disease (disorder) 1.0
SNOMEDCT 360470001 Chronic mucus hypersecretion (disorder) 1.0
SNOMEDCT 45145000 Unilateral emphysema (situation) 1.0
SNOMEDCT 61937009 Simple chronic bronchitis (disorder) 1.0
SNOMEDCT 68328006 Centriacinar emphysema (disorder) 1.0
SNOMEDCT 74417001 Mucopurulent chronic bronchitis (disorder) 1.0
SNOMEDCT 87433001 Pulmonary emphysema (disorder) 1.0
SNOMEDCT 89549007 Catarrhal bronchitis (disorder) 1.0
SNOMEDCT 233673002 Drug-induced bronchiolitis obliterans (disorder) 1.0
SNOMEDCT 10692761000119107 Asthma-chronic obstructive pulmonary disease overlap syndrome (disorder) 1.0
SNOMEDCT 16003001 Giant bullous emphysema (disorder) 1.0
SNOMEDCT 195953005 Mixed simple and mucopurulent chronic bronchitis (disorder) 1.0
SNOMEDCT 195957006 Chronic bullous emphysema (disorder) 1.0
SNOMEDCT 195958001 Segmental bullous emphysema (disorder) 1.0
SNOMEDCT 195963002 Acute vesicular emphysema (disorder) 1.0
SNOMEDCT 233675009 Toxic emphysema (disorder) 1.0
SNOMEDCT 233677001 Scar emphysema (disorder) 1.0
SNOMEDCT 313296004 Mild chronic obstructive pulmonary disease (disorder) 1.0
SNOMEDCT 313299006 Severe chronic obstructive pulmonary disease (disorder) 1.0
SNOMEDCT 49691004 Occupational bronchitis (disorder) 1.0
SNOMEDCT 4981000 Panacinar emphysema (disorder) 1.0
SNOMEDCT 52571006 Chronic tracheobronchitis (disorder) 1.0
SNOMEDCT 63480004 Chronic bronchitis (disorder) 1.0
SNOMEDCT 66987001 Congenital lobar emphysema (disorder) 1.0
SNOMEDCT 84409004 Fetid chronic bronchitis (disorder) 1.0
SNOMEDCT 866901000000103 Eosinophilic bronchitis (disorder) 1.0

Publication

Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, and thrombocytopenic events: whole population cohort study in 46 million adults in England

CVD-COVID-UK consortium, William N Whiteley, Samantha Ip, Jennifer A Cooper, Thomas Bolton, Spencer Keene, Venexia Walker, Rachel Denholm, Ashley Akbari, Efosa Omigie, Sam Hollings, Emanuele Di Angelantonio, Spiros Denaxas, Angela Wood, Jonathan A C Sterne, Cathie Sudlow

medRxiv 2021.08.18.21262222; doi: https://doi.org/10.1101/2021.08.18.21262222